IL17A and rheumatoid arthritis: Khandpur et al. have shown that TNF, IL-17, and anti-citrullinated protein antibodies (ACPA) promote NET release by neutrophils from patients with RA, whereas therapeutic blockade of TNF function has been shown to decrease the extensive NET generation that characterizes RA patients.